AUS
NZ
UK
CA
USA
IND
On July 17, 2026, Citigroup Global Markets Holdings Inc. introduced a structured debt issuance featuring autocallable buffered notes maturing July 21, 2028, linked to the MSCI Emerging Markets Index. These notes provide an automatic early redemption option with a 21.90% premium if the index closes at or above its initial level on July 30, 2027. However, investors face substantial downside risk if holding until maturity and the index declines beyond 15%. The $5.377 million offering targets investors seeking emerging markets exposure with built-in structural safeguards and redemption flexibility.
Key Points
- NYSE ticker: C-PR
- Citigroup priced autocallable buffered notes with $1,000 principal per security, maturing July 21, 2028, unless called early
- 21.90% premium payable at first valuation date (July 30, 2027) if MSCI Emerging Markets Index closes at or above initial level; issue price $1,000 with estimated value $975.20 per note
- Upside participation rate of 125.00% at maturity if notes are not called early; 15.00% downside buffer limits protection against losses
Structured Note Framework Focused on Emerging Markets Index Performance
These notes, issued by Citigroup Global Markets Holdings Inc. and fully guaranteed by Citigroup Inc., are complex structured debt instruments without periodic interest payments or principal guarantees at maturity. Investor returns depend solely on the MSCI Emerging Markets Index (ticker: MXEF) performance from pricing on July 17, 2026, with an initial index level of 1,620.66.
The notes feature three potential payout scenarios based on redemption timing and index performance: automatic early redemption with premium if the index meets or exceeds its initial level on the first valuation date; principal protection if the index declines but remains above the 15% buffer threshold; and losses if the index falls below the buffer value of 1,377.561.
Automatic Early Redemption Provides Fixed 21.90% Premium Incentive
A key feature is the automatic early redemption on July 30, 2027, if the MSCI Emerging Markets Index closes at or above 1,620.66. In this case, notes will redeem three business days later, paying investors $1,000 plus a 21.90% premium, totaling $1,219 per note. This structure encourages investors to anticipate stable or appreciating index levels within the first year.
However, the fixed 21.90% premium does not increase with index gains beyond the initial level, potentially capping upside if the index rallies strongly. Upon early redemption, notes cease to exist, ending any further participation in index appreciation.
Maturity Payoff and Buffer Protection Details
If notes are not called early and mature on July 21, 2028, investor returns depend on final index performance. If the index closes at or above 1,620.66, investors receive $1,000 plus 125.00% of the index’s appreciation. For example, a 10% index gain results in $1,125 per note. This upside participation rate enhances returns but is not one-to-one.
The 15.00% buffer protects principal if the index declines but remains above 1,377.561. In this scenario, investors receive the full $1,000 principal. If the index falls below the buffer, losses increase dollar-for-dollar beyond the 15% threshold, exposing investors to significant capital erosion.
Pricing, Fees, and Valuation Insights
Priced at $1,000 per note, the $5.377 million offering comprises 5,377 securities. Citigroup Global Markets Inc. (CGMI) served as principal underwriter, charging a $15 underwriting fee per note, totaling $80,655. Placement agents J.P. Morgan Securities LLC and JPMorgan Chase Bank, N.A. received $15 per note sold to non-fiduciary accounts, with fiduciary sales incurring no fees, resulting in a $985 net issue price for those investors.
The estimated value at pricing was $975.20 per note, approximately $24.80 below the issue price. Citigroup notes this estimate is based on proprietary models and internal funding rates and does not reflect actual profit or secondary market prices, indicating potential immediate negative unrealized returns for early sellers.
Liquidity and Credit Risks Highlighted for Investors
The offering is unlisted with no exchange trading, requiring investors to accept limited or no liquidity and the risk of nonpayment if Citigroup or its parent defaults. Identified by CUSIP 17334BDQ6 and ISIN US17334BDQ68, these notes lack a designated trading venue, complicating early exit strategies.
Payments depend on the creditworthiness of Citigroup Global Markets Holdings Inc. and Citigroup Inc. Although guaranteed by the parent, these subordinated debt obligations are not FDIC insured. Severe credit stress could result in partial or total loss regardless of index performance.
Dependence on MSCI Emerging Markets Index and Valuation Timing
Investor outcomes hinge on MSCI Emerging Markets Index levels at two valuation dates: July 30, 2027, and July 18, 2028. These dates may be postponed due to market disruptions or non-trading days, adding timing uncertainty. The index, comprising emerging market equities, is subject to high volatility from currency, political, and economic factors.
Issuer Hedging and Profit Dynamics
Citigroup and affiliates may profit from hedging activities related to this offering, even if note values decline. Hedging costs contribute to the $24.80 gap between issue price and estimated value. The issuer benefits from hedging gains beyond the fixed investor premium, illustrating the asymmetry typical in structured products.
Risk Factors and Potential for Total Loss
The documentation warns investors may lose their entire investment if the index declines more than 85% below the initial level, eroding the buffer protection. Losses increase dollar-for-dollar beyond the 15% buffer, with total loss possible in extreme scenarios. Additional risks include issuer credit and liquidity concerns. These notes are unsuitable for investors averse to emerging market volatility, credit risk, or illiquid structured products.
Regulatory Filings and Documentation Requirements
Issued under SEC Registration Statements 333-293732 and 333-293732-02, the pricing supplement filed under Rule 424(b)(2) supplements the effective registration. Investors must review the pricing supplement alongside product supplement No. EA-02-12, underlying supplement No. 13, prospectus supplement, and base prospectus, all dated February 25, 2026, for comprehensive terms and disclosures.
The SEC has neither approved nor disapproved the securities nor verified disclosure accuracy. Prospective investors should carefully analyze all documents and consult financial advisors before investing in these complex structured notes.
